← Back to searchRecruitingRecruiting
The National Amyotrophic Lateral Sclerosis Registry
NCT01772602 · Centers for Disease Control and Prevention
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
About this study
The National ALS Registry's Research Notification System allows person with ALS to participate in clinical trials.
Eligibility criteria
Inclusion Criteria:
\- U.S. citizens 18 years of age or older
Exclusion Criteria:
\-
Study design
Enrollment target: 30000 participants
Age groups: adult, older_adult
Timeline
Starts: 2010-10
Estimated completion: 2040-12
Last updated: 2025-04-09
Primary outcomes
- • The National Amyotrophic Lateral Sclerosis (ALS) Registry (1 year)
Sponsor
Centers for Disease Control and Prevention · fed
With: US Department of Veterans Affairs, Centers for Medicare and Medicaid Services
Contacts & investigators
ContactPaul Mehta, MD · contact · PMehta1@cdc.gov · 770-488-0556
ContactKevin Horton, DrPH, MSPH · contact · dhorton@cdc.gov · 770-488-1555
InvestigatorPaul Mehta, MD · principal_investigator, Centers for Disease Control and Prevention
All locations (1)
CDCRecruiting
Atlanta, Georgia, United States